Top

Reactions Weekly

Published in:

01-11-2023 | Cefazolin | Case report

Cefazolin/levofloxacin/linezolid

Cutaneous rash, thrombocytopenia and encephalopathy: 3 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Petithomme-Nanrocki M, et al. Early switching from intravenous to oral antibiotic therapy in bone and joint infections associated with methicillin-susceptible Staphylococcus aureus bacteremia. Infectious Diseases Now 53: No. 6, Sep 2023. Available from: URL: http://doi.org/10.1016/j.idnow.2023.104739

Title: Cefazolin/levofloxacin/linezolid
Cutaneous rash, thrombocytopenia and encephalopathy: 3 case reports
Publication date: 01-11-2023
Publisher: Springer International Publishing
Keywords: Cefazolin
Linezolid
Joint Infection
Levofloxacin
Encephalopathy
Thrombocytopenia
Antibiotic
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-48692-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cefazolin/levofloxacin/linezolid

Cutaneous rash, thrombocytopenia and encephalopathy: 3 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Multiple drugs

Multiple drugs

Etanercept

Azathioprine

Bumetanide/dapagliflozin/losartan

Atropine/epinephrine